IBDEI1CZ ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24070,1,2,0)
 ;;=2^MALIG CARCINOID,NONBOWEL AND OTH SITE
 ;;^UTILITY(U,$J,358.3,24070,2)
 ;;=^336507
 ;;^UTILITY(U,$J,358.3,24071,0)
 ;;=209.00^^133^1468^39
 ;;^UTILITY(U,$J,358.3,24071,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24071,1,1,0)
 ;;=1^209.00
 ;;^UTILITY(U,$J,358.3,24071,1,2,0)
 ;;=2^MALIG CARCINOID,SMALL INTESTINE
 ;;^UTILITY(U,$J,358.3,24071,2)
 ;;=^336721
 ;;^UTILITY(U,$J,358.3,24072,0)
 ;;=156.9^^133^1468^12
 ;;^UTILITY(U,$J,358.3,24072,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24072,1,1,0)
 ;;=1^156.9
 ;;^UTILITY(U,$J,358.3,24072,1,2,0)
 ;;=2^CHOLANGIOCARCINOMA
 ;;^UTILITY(U,$J,358.3,24072,2)
 ;;=^267102
 ;;^UTILITY(U,$J,358.3,24073,0)
 ;;=286.9^^133^1468^13
 ;;^UTILITY(U,$J,358.3,24073,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24073,1,1,0)
 ;;=1^286.9
 ;;^UTILITY(U,$J,358.3,24073,1,2,0)
 ;;=2^COAGULATION DEFECTS
 ;;^UTILITY(U,$J,358.3,24073,2)
 ;;=^87267
 ;;^UTILITY(U,$J,358.3,24074,0)
 ;;=459.0^^133^1468^20
 ;;^UTILITY(U,$J,358.3,24074,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24074,1,1,0)
 ;;=1^459.0
 ;;^UTILITY(U,$J,358.3,24074,1,2,0)
 ;;=2^HEMORRHAGE NOS
 ;;^UTILITY(U,$J,358.3,24074,2)
 ;;=^55877
 ;;^UTILITY(U,$J,358.3,24075,0)
 ;;=176.9^^133^1468^21
 ;;^UTILITY(U,$J,358.3,24075,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24075,1,1,0)
 ;;=1^176.9
 ;;^UTILITY(U,$J,358.3,24075,1,2,0)
 ;;=2^KAPOSI'S SARCOMA, NOS
 ;;^UTILITY(U,$J,358.3,24075,2)
 ;;=^107993
 ;;^UTILITY(U,$J,358.3,24076,0)
 ;;=161.9^^133^1468^22
 ;;^UTILITY(U,$J,358.3,24076,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24076,1,1,0)
 ;;=1^161.9
 ;;^UTILITY(U,$J,358.3,24076,1,2,0)
 ;;=2^LARYNGEAL CANCER
 ;;^UTILITY(U,$J,358.3,24076,2)
 ;;=^267128
 ;;^UTILITY(U,$J,358.3,24077,0)
 ;;=208.90^^133^1468^23
 ;;^UTILITY(U,$J,358.3,24077,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24077,1,1,0)
 ;;=1^208.90
 ;;^UTILITY(U,$J,358.3,24077,1,2,0)
 ;;=2^LEUKEMIA,UNSP CELL TYPE w/o REM
 ;;^UTILITY(U,$J,358.3,24077,2)
 ;;=^336874
 ;;^UTILITY(U,$J,358.3,24078,0)
 ;;=140.9^^133^1468^25
 ;;^UTILITY(U,$J,358.3,24078,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24078,1,1,0)
 ;;=1^140.9
 ;;^UTILITY(U,$J,358.3,24078,1,2,0)
 ;;=2^LIP CANCER,UNSPEC
 ;;^UTILITY(U,$J,358.3,24078,2)
 ;;=^266994
 ;;^UTILITY(U,$J,358.3,24079,0)
 ;;=155.0^^133^1468^26
 ;;^UTILITY(U,$J,358.3,24079,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24079,1,1,0)
 ;;=1^155.0
 ;;^UTILITY(U,$J,358.3,24079,1,2,0)
 ;;=2^LIVER CANCER
 ;;^UTILITY(U,$J,358.3,24079,2)
 ;;=^73526
 ;;^UTILITY(U,$J,358.3,24080,0)
 ;;=200.60^^133^1468^28
 ;;^UTILITY(U,$J,358.3,24080,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24080,1,1,0)
 ;;=1^200.60
 ;;^UTILITY(U,$J,358.3,24080,1,2,0)
 ;;=2^LYMPHOMA,ANAPLASTIC LARGE CELL,UNSPEC
 ;;^UTILITY(U,$J,358.3,24080,2)
 ;;=^335299
 ;;^UTILITY(U,$J,358.3,24081,0)
 ;;=200.20^^133^1468^29
 ;;^UTILITY(U,$J,358.3,24081,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24081,1,1,0)
 ;;=1^200.20
 ;;^UTILITY(U,$J,358.3,24081,1,2,0)
 ;;=2^LYMPHOMA,BURKITT'S,UNSPEC
 ;;^UTILITY(U,$J,358.3,24081,2)
 ;;=^17529
 ;;^UTILITY(U,$J,358.3,24082,0)
 ;;=201.90^^133^1468^30
 ;;^UTILITY(U,$J,358.3,24082,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24082,1,1,0)
 ;;=1^201.90
 ;;^UTILITY(U,$J,358.3,24082,1,2,0)
 ;;=2^LYMPHOMA,HODGKIN'S,UNSPEC
 ;;^UTILITY(U,$J,358.3,24082,2)
 ;;=^267430
 ;;^UTILITY(U,$J,358.3,24083,0)
 ;;=200.70^^133^1468^31
 ;;^UTILITY(U,$J,358.3,24083,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,24083,1,1,0)
 ;;=1^200.70
 ;;^UTILITY(U,$J,358.3,24083,1,2,0)
 ;;=2^LYMPHOMA,LARGE CELL,UNSPEC
 ;;^UTILITY(U,$J,358.3,24083,2)
 ;;=^335300
 ;;^UTILITY(U,$J,358.3,24084,0)
 ;;=200.40^^133^1468^32
 ;;
 ;;$END ROU IBDEI1CZ
